Mayflower Financial Advisors, LLC Ptc Therapeutics, Inc. Transaction History

Mayflower Financial Advisors, LLC

  • $629 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 19, 2022
BUY
$41.85 - $53.85 $172,129 - $221,485
4,113 New
4,113 $206,000
Q2 2022

Jul 15, 2022
SELL
$25.6 - $45.23 $76 - $135
-3 Reduced 0.05%
6,152 $246,000
Q1 2022

Apr 21, 2022
BUY
$33.33 - $44.6 $205,146 - $274,513
6,155 New
6,155 $230,000
Q3 2021

Oct 26, 2021
SELL
$37.01 - $44.74 $176,537 - $213,409
-4,770 Closed
0 $0
Q2 2021

Jul 29, 2021
BUY
$37.95 - $49.37 $181,021 - $235,494
4,770 New
4,770 $202,000

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.27B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Mayflower Financial Advisors, LLC Portfolio

Follow Mayflower Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email